AAAAAA

   
Results: 1-25 | 26-50 | 51-58
Results: 1-25/58
RENAL CLEARANCE, TISSUE DISTRIBUTION, AND CA-125 RESPONSES IN A PHASE-I TRIAL OF SURAMIN
Authors: HUTSON PR TUTSCH KD RAGO R ARZOOMANIAN R ALBERTI D POMPLUN M CHURCH D MARNOCHA R CHENG AL KEHRLI N WILDING G
Citation: Pr. Hutson et al., RENAL CLEARANCE, TISSUE DISTRIBUTION, AND CA-125 RESPONSES IN A PHASE-I TRIAL OF SURAMIN, Clinical cancer research, 4(6), 1998, pp. 1429-1436
MEGESTROL-ACETATE ANTAGONIZES CISPLATIN CYTOTOXICITY
Authors: PU YS CHENG AL CHEN J GUAN JY LU SH LAI MK HSIEH CY
Citation: Ys. Pu et al., MEGESTROL-ACETATE ANTAGONIZES CISPLATIN CYTOTOXICITY, Anti-cancer drugs, 9(8), 1998, pp. 733-738
BCL-2 PREVENTS TOPOISOMERASE-II INHIBITOR GL331-INDUCED APOPTOSIS IS MEDIATED BY DOWN-REGULATION OF POLY(ADP-RIBOSE)POLYMERASE ACTIVITY
Authors: KUO ML SHEN SC YANG CH CHUANG SE CHENG AL HUANG TS
Citation: Ml. Kuo et al., BCL-2 PREVENTS TOPOISOMERASE-II INHIBITOR GL331-INDUCED APOPTOSIS IS MEDIATED BY DOWN-REGULATION OF POLY(ADP-RIBOSE)POLYMERASE ACTIVITY, Oncogene, 17(17), 1998, pp. 2225-2234
SEQUENCE-DEPENDENT SYNERGISM OF PACLITAXEL AND 5-FLUOROURACIL IN THE TREATMENT OF GASTRIC-CANCER - IN-VITRO AND PILOT CLINICAL-STUDIES
Authors: YEH KH CHENG AL LIN JF MA IF HSU CH LU YS CHEN YC
Citation: Kh. Yeh et al., SEQUENCE-DEPENDENT SYNERGISM OF PACLITAXEL AND 5-FLUOROURACIL IN THE TREATMENT OF GASTRIC-CANCER - IN-VITRO AND PILOT CLINICAL-STUDIES, Annals of oncology, 9, 1998, pp. 225-225
CISPLATIN, ETOPOSIDE, AND WEEKLY HIGH-DOSE 5-FLUOROURACIL AND LEUCOVORIN INFUSION (PE-HDFL) - A VERY EFFECTIVE REGIMEN WITH GOOD PATIENTS COMPLIANCE FOR ADVANCED GASTRIC-CANCER
Authors: CHENG AL YEH KH LIN JT HSU C LIU MY
Citation: Al. Cheng et al., CISPLATIN, ETOPOSIDE, AND WEEKLY HIGH-DOSE 5-FLUOROURACIL AND LEUCOVORIN INFUSION (PE-HDFL) - A VERY EFFECTIVE REGIMEN WITH GOOD PATIENTS COMPLIANCE FOR ADVANCED GASTRIC-CANCER, Anticancer research, 18(2B), 1998, pp. 1267-1272
DETECTION OF CIRCULATING CANCER-CELLS BY NESTED REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION OF CYTOKERATIN-19 (K19)-POSSIBLE CLINICAL-SIGNIFICANCE IN ADVANCED GASTRIC-CANCER
Authors: YEH KH CHEN YC YEH SH CHEN CP LIN JTL CHENG AL
Citation: Kh. Yeh et al., DETECTION OF CIRCULATING CANCER-CELLS BY NESTED REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION OF CYTOKERATIN-19 (K19)-POSSIBLE CLINICAL-SIGNIFICANCE IN ADVANCED GASTRIC-CANCER, Anticancer research, 18(2B), 1998, pp. 1283-1286
HIGH-DOSE TAMOXIFEN REVERSES DRUG-RESISTANCE TO CISPLATIN AND ETOPOSIDE IN A PATIENT WITH ADVANCED LARGE-CELL CARCINOMA OF LUNG (VOL 17, PG1341, 1997)
Authors: YEH KH CHENG AL
Citation: Kh. Yeh et Al. Cheng, HIGH-DOSE TAMOXIFEN REVERSES DRUG-RESISTANCE TO CISPLATIN AND ETOPOSIDE IN A PATIENT WITH ADVANCED LARGE-CELL CARCINOMA OF LUNG (VOL 17, PG1341, 1997), Anticancer research, 18(1A), 1998, pp. 93-93
THYMIC CARCINOMA WITH AUTOIMMUNE SYNDROME - SUCCESSFUL TREATMENT WITHWEEKLY INFUSIONAL HIGH-DOSE 5-FLUOROURACIL AND LEUCOVORIN (VOL 17, PG1331, 1997)
Authors: HSU CH YEH KH CHENG AL
Citation: Ch. Hsu et al., THYMIC CARCINOMA WITH AUTOIMMUNE SYNDROME - SUCCESSFUL TREATMENT WITHWEEKLY INFUSIONAL HIGH-DOSE 5-FLUOROURACIL AND LEUCOVORIN (VOL 17, PG1331, 1997), Anticancer research, 18(1A), 1998, pp. 93-93
RELATIVELY LOW EXPRESSION OF MULTIDRUG RESISTANCE-1 (MDR-1) AND ITS POSSIBLE CLINICAL IMPLICATION IN GASTRIC CANCERS
Authors: YEH KH CHEN CL SHUN CT LIN JT LEE WJ LEE PH CHEN YC CHENG AL
Citation: Kh. Yeh et al., RELATIVELY LOW EXPRESSION OF MULTIDRUG RESISTANCE-1 (MDR-1) AND ITS POSSIBLE CLINICAL IMPLICATION IN GASTRIC CANCERS, Journal of clinical gastroenterology, 26(4), 1998, pp. 274-278
HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL (PBSC) SUPPORT USING AN INNOVATIVE MOBILIZATION REGIMEN IN PATIENTS WITH HIGH-RISK PRIMARY OR CHEMORESPONSIVE METASTATIC BREAST CANCERS
Authors: YEH KH LIN MT LIN DT TANG JL LUI LT LIN JF CHANG YS CHENG AL YU SC CHANG KJ CHEN YC
Citation: Kh. Yeh et al., HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL (PBSC) SUPPORT USING AN INNOVATIVE MOBILIZATION REGIMEN IN PATIENTS WITH HIGH-RISK PRIMARY OR CHEMORESPONSIVE METASTATIC BREAST CANCERS, Breast cancer research and treatment, 49(3), 1998, pp. 237-244
HIGH EXPRESSION OF THYMIDYLATE SYNTHASE IS ASSOCIATED WITH THE DRUG-RESISTANCE OF GASTRIC-CARCINOMA TO HIGH-DOSE 5-FLUOROURACIL-BASED SYSTEMIC CHEMOTHERAPY
Authors: YEH KH SHUN CT CHEN CL LIN JT LEE WJ LEE PH CHEN YC CHENG AL
Citation: Kh. Yeh et al., HIGH EXPRESSION OF THYMIDYLATE SYNTHASE IS ASSOCIATED WITH THE DRUG-RESISTANCE OF GASTRIC-CARCINOMA TO HIGH-DOSE 5-FLUOROURACIL-BASED SYSTEMIC CHEMOTHERAPY, Cancer, 82(9), 1998, pp. 1626-1631
SYSTEMIC CHEMOTHERAPY ALONE FOR PATIENTS WITH NON-ACQUIRED IMMUNODEFICIENCY SYNDROME-RELATED CENTRAL-NERVOUS-SYSTEM LYMPHOMA - A PILOT-STUDY OF THE BOMES PROTOCOL
Authors: CHENG AL YEH KH UEN WC HUNG RL LIU MY WANG CH
Citation: Al. Cheng et al., SYSTEMIC CHEMOTHERAPY ALONE FOR PATIENTS WITH NON-ACQUIRED IMMUNODEFICIENCY SYNDROME-RELATED CENTRAL-NERVOUS-SYSTEM LYMPHOMA - A PILOT-STUDY OF THE BOMES PROTOCOL, Cancer, 82(10), 1998, pp. 1946-1951
GASTRIC-CANCER ASSOCIATED WITH ACUTE DISSEMINATED INTRAVASCULAR COAGULATION - SUCCESSFUL INITIAL TREATMENT WITH WEEKLY 24-HOUR INFUSION OF HIGH-DOSE 5-FLUOROURACIL AND LEUCOVORIN
Authors: YEH KH CHENG AL
Citation: Kh. Yeh et Al. Cheng, GASTRIC-CANCER ASSOCIATED WITH ACUTE DISSEMINATED INTRAVASCULAR COAGULATION - SUCCESSFUL INITIAL TREATMENT WITH WEEKLY 24-HOUR INFUSION OF HIGH-DOSE 5-FLUOROURACIL AND LEUCOVORIN, British Journal of Haematology, 100(4), 1998, pp. 769-772
5-FLUOROURACIL RELATED ENCEPHALOPATHY - AT LEAST 2 DISTINCT PATHOGENETIC MECHANISMS EXIST - REPLY
Authors: YEH KH CHENG AL
Citation: Kh. Yeh et Al. Cheng, 5-FLUOROURACIL RELATED ENCEPHALOPATHY - AT LEAST 2 DISTINCT PATHOGENETIC MECHANISMS EXIST - REPLY, British Journal of Cancer, 77(10), 1998, pp. 1711-1712
INHIBITION OF THE MEMBRANE TRANSLOCATION AND ACTIVATION OF PROTEIN-KINASE-C, AND POTENTIATION OF DOXORUBICIN-INDUCED APOPTOSIS OF HEPATOCELLULAR-CARCINOMA CELLS BY TAMOXIFEN
Authors: CHENG AL CHUANG SE FINE RL YEH KH LIAO CM LAY JD CHEN DS
Citation: Al. Cheng et al., INHIBITION OF THE MEMBRANE TRANSLOCATION AND ACTIVATION OF PROTEIN-KINASE-C, AND POTENTIATION OF DOXORUBICIN-INDUCED APOPTOSIS OF HEPATOCELLULAR-CARCINOMA CELLS BY TAMOXIFEN, Biochemical pharmacology, 55(4), 1998, pp. 523-531
FACTORS ASSOCIATED WITH THE THERAPEUTIC EFFICACY OF RETINOIC ACIDS ONMALIGNANT-LYMPHOMAS
Authors: CHENG AL CHUANG SF SU IJ
Citation: Al. Cheng et al., FACTORS ASSOCIATED WITH THE THERAPEUTIC EFFICACY OF RETINOIC ACIDS ONMALIGNANT-LYMPHOMAS, Journal of the Formosan Medical Association, 96(7), 1997, pp. 525-534
MVP (MITOMYCIN-C, VINBLASTINE, CISPLATIN) SALVAGE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY METASTATIC BREAST-CANCER
Authors: HSU C YEH KH HONG RL YANG CH LIN MT CHEN YC CHENG AL
Citation: C. Hsu et al., MVP (MITOMYCIN-C, VINBLASTINE, CISPLATIN) SALVAGE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY METASTATIC BREAST-CANCER, Journal of the Formosan Medical Association, 96(3), 1997, pp. 185-188
EXPRESSION OF P-GLYCOPROTEIN AND P53 IN ADVANCED HEPATOCELLULAR-CARCINOMA TREATED BY SINGLE-AGENT CHEMOTHERAPY - CLINICAL CORRELATION
Authors: CHOU YY CHENG AL HSU HC
Citation: Yy. Chou et al., EXPRESSION OF P-GLYCOPROTEIN AND P53 IN ADVANCED HEPATOCELLULAR-CARCINOMA TREATED BY SINGLE-AGENT CHEMOTHERAPY - CLINICAL CORRELATION, Journal of gastroenterology and hepatology, 12(8), 1997, pp. 569-575
STABILITY OF CURCUMIN IN BUFFER SOLUTIONS AND CHARACTERIZATION OF ITSDEGRADATION PRODUCTS
Authors: WANG YJ PAN MH CHENG AL LIN LI HO YS HSIEH CY LIN JK
Citation: Yj. Wang et al., STABILITY OF CURCUMIN IN BUFFER SOLUTIONS AND CHARACTERIZATION OF ITSDEGRADATION PRODUCTS, Journal of pharmaceutical and biomedical analysis, 15(12), 1997, pp. 1867-1876
INFREQUENT HMSH2 MUTATIONS IN SPORADIC GASTRIC ADENOCARCINOMA WITH MICROSATELLITE INSTABILITY
Authors: WU MS SHEU JC SHUN CT LEE WJ WANG JT WANG TH CHENG AL LIN JT
Citation: Ms. Wu et al., INFREQUENT HMSH2 MUTATIONS IN SPORADIC GASTRIC ADENOCARCINOMA WITH MICROSATELLITE INSTABILITY, Cancer letters, 112(2), 1997, pp. 161-166
TRANSFORMING-GROWTH-FACTOR BETA-1 ATTENUATES CERAMIDE-INDUCED CPP32 YAMA ACTIVATION AND APOPTOSIS IN HUMAN LEUKEMIC HL-60 CELLS/
Authors: KUO ML CHEN CW JEE SH CHUANG SE CHENG AL
Citation: Ml. Kuo et al., TRANSFORMING-GROWTH-FACTOR BETA-1 ATTENUATES CERAMIDE-INDUCED CPP32 YAMA ACTIVATION AND APOPTOSIS IN HUMAN LEUKEMIC HL-60 CELLS/, Biochemical journal, 327, 1997, pp. 663-667
A PHASE-II STUDY OF WEEKLY 24-HOUR INFUSION OF HIGH-DOSE 5-FLUOROURACIL AND LEUCOVORIN (HDFL) IN THE TREATMENT OF RECURRENT OR METASTATIC COLORECTAL CANCERS
Authors: YEH KH CHENG AL LIN MT HONG RL HSU CH LIN JF CHANG KJ LEE PH CHEN YC
Citation: Kh. Yeh et al., A PHASE-II STUDY OF WEEKLY 24-HOUR INFUSION OF HIGH-DOSE 5-FLUOROURACIL AND LEUCOVORIN (HDFL) IN THE TREATMENT OF RECURRENT OR METASTATIC COLORECTAL CANCERS, Anticancer research, 17(5B), 1997, pp. 3867-3871
PROGNOSTIC-SIGNIFICANCE OF IMMUNOPHENOTYPES IN ADULT LYMPHOBLASTIC LYMPHOMAS
Authors: YEH KH CHENG AL SU IJ LIN MT TIEN HF SHEN MC WANG CH CHEN YC
Citation: Kh. Yeh et al., PROGNOSTIC-SIGNIFICANCE OF IMMUNOPHENOTYPES IN ADULT LYMPHOBLASTIC LYMPHOMAS, Anticancer research, 17(3C), 1997, pp. 2269-2272
THYMIC CARCINOMA WITH AUTOIMMUNE SYNDROME - SUCCESSFUL TREATMENT WITHWEEKLY INFUSIONAL HIGH-DOSE 5-FLUOROURACIL AND LEUCOVORIN
Authors: HSU CH YEH KH CHENG AL
Citation: Ch. Hsu et al., THYMIC CARCINOMA WITH AUTOIMMUNE SYNDROME - SUCCESSFUL TREATMENT WITHWEEKLY INFUSIONAL HIGH-DOSE 5-FLUOROURACIL AND LEUCOVORIN, Anticancer research, 17(2B), 1997, pp. 1331-1334
HIGH-DOSE TAMOXIFEN REVERSES DRUG-RESISTANCE TO CISPLATIN AND ETOPOSIDE IN A PATIENT WITH ADVANCED LARGE-CELL CARCINOMA OF LUNG
Authors: YEH KH CHENG AL
Citation: Kh. Yeh et Al. Cheng, HIGH-DOSE TAMOXIFEN REVERSES DRUG-RESISTANCE TO CISPLATIN AND ETOPOSIDE IN A PATIENT WITH ADVANCED LARGE-CELL CARCINOMA OF LUNG, Anticancer research, 17(2B), 1997, pp. 1341-1343
Risultati: 1-25 | 26-50 | 51-58